PAVmed Inc.
For the period ended Dec 31, 2024. Filed Mar 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 24, 2025
PAVM$1.63+3.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(in thousands except number of shares and per share data)
| December 31, 2024 | December 31, 2023 | |
|---|---|---|
| Assets: | ||
| Current assets: | ||
| Cash | $1,185 | $19,639 |
| Accounts receivable | 18 | 61 |
| Inventory | — | 278 |
| Prepaid expenses, deposits, and other current assets | 961 | 4,520 |
| Total current assets | 2,164 | 24,498 |
| Fixed assets, net | 151 | 1,783 |
| Operating lease right-of-use assets | 2,500 | 4,267 |
| Intangible assets, net | — | 1,424 |
| Equity method investment - at fair value | 25,637 | — |
| Other assets | 208 | 1,147 |
| Total assets | $30,660 | $33,119 |
| Liabilities, Preferred Stock and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $657 | $1,786 |
| Accrued expenses and other current liabilities | 5,176 | 6,626 |
| Operating lease liabilities, current portion | 513 | 1,565 |
| Senior Secured Convertible Notes - at fair value | 29,100 | 44,200 |
| Total current liabilities | 35,446 | 54,177 |
| Operating lease liabilities, less current portion | 2,247 | 2,960 |
| Total liabilities | 37,693 | 57,137 |
| Commitments and contingencies (Note 11) | - | - |
| Stockholders’ Equity: | ||
| Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,412,865 at December 31, 2024 and 1,305,213 shares at December 31, 2023 | 3,316 | 2,993 |
| Common stock, $0.001 par value. Authorized, 250,000,000 shares (Note 16); 11,198,977 and 8,578,505 shares outstanding as of December 31, 2024 and December 31, 2023, respectively | 11 | 9 |
| Additional paid-in capital | 249,143 | 237,600 |
| Accumulated deficit | (254,965) | (294,433) |
| Total PAVmed Inc. Stockholders’ Equity (Deficit) | (2,495) | (53,831) |
| Noncontrolling interests | (4,538) | 29,813 |
| Total Stockholders’ Equity (Deficit) | (7,033) | (24,018) |
| Total Liabilities and Stockholders’ Equity (Deficit) | $30,660 | $33,119 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.